Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686972 · ClinicalTrials.gov registry record · Phase 2
The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT00686972: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT00686972 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686972, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate changes in sugar, metabolism, heart function and changes in body composition as patients lose weight following bariatric surgery. The investigators will compare improvements of the above changes as a function of the four different types of bariatric surgery. The investigators believe the most beneficial and safest procedure will be the Roux-en-Y.
Interventions
- DRUG GLP-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00686972
The ClinicalTrials.gov registry entry for NCT00686972 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GLP-1 is the first listed.
NCT00686972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00686972 about?
NCT00686972 is a clinical study titled "The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition". This study is being conducted to evaluate changes in sugar, metabolism, heart function and changes in body composition as patients lose weight following bariatric surgery. The investigators will compare improvements of the above changes as a function of the four different types of bariatric surgery....
What is the current status of trial NCT00686972?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2007-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00686972?
The interventions under investigation include: GLP-1 (DRUG).
Who is sponsoring clinical trial NCT00686972?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.